Proxy voting advisory firm Egan Jones Proxy Services has recommended that shareholders of Amylin Pharmaceuticals vote on Eastbourne Capital Management’s white proxy card and support cha
Proxy voting advisory firm Egan Jones Proxy Services has recommended that shareholders of Amylin Pharmaceuticals vote on Eastbourne Capital Management’s white proxy card and support change to the 12 member board of directors.
Egan Jones’ recommendation follows recommendations recently issued by RiskMetrics Group, Glass Lewis and Proxy Governance, all supporting the election of Eastbourne and Icahn nominees.
In its report, Egan Jones has recommended Amylin shareholders vote Eastbourne’s white proxy card for the election of Eastbourne nominees, Dr. Kathleen Behrens and Jay Sherwood, along with Icahn nominee, Dr. Alex Denner.
Other proxy firms have also recommended the election of Eastbourne nominee Charles Fleischman.
Richard J. Barry, Eastbourne founder and portfolio manager, says: ‘Egan Jones’ evaluation and support for the ‘election of a significant number’ of Eastbourne’s and Icahn’s nominees, coming after numerous other independent recommendations in support of change to the Amylin Board, should make it unequivocally clear that it is time for new leadership at Amylin. We continue to urge Amylin shareholders to vote for all three of our nominees – Dr. Kathleen Behrens, Charles Fleischman and Jay Sherwood – on Eastbourne’s white proxy card today.’
